What brokers need to know about pharmacy cost spikes after 1/1
Table of Contents
- The post-renewal wake-up call for brokers
- Why pharmacy costs spike after 1/1
- The real issue: PBM misalignment and lack of transparency
- The broker’s role after January 1: From firefighting to strategy
- What brokers can do right now to regain control
- How Intercept Rx supports brokers post-1/1
- Key takeaways for brokers
The post-renewal wake-up call for brokers
By early January, most brokers know the drill: January 1 resets rarely go as planned especially when it comes to pharmacy benefits. Plans kick in, deductions reset, and ideally everything should run smoothly. But for many employers and their members, the reality is quite different.
Within a few weeks of the new plan year, brokers often begin hearing the same questions from clients:
- “Why are prescriptions suddenly more expensive?”
- “Why did a medication stop being covered?”
- “Why are employees confused and frustrated?”
These concerns are symptoms of deeper issues in plan design, benefit communication, and how pharmacy benefits are managed under traditional Pharmacy Benefit Managers (PBMs).
And this year, the stakes are even higher.
Industry trend forecasts show that prescription drug cost trends are projected to range from 10% to 12% in 2026¹, continuing significant annual growth and underlining the ongoing challenge employers face in managing pharmacy spend.
For brokers, that statistic isn’t just a number. It reflects real pressure on employer health plans, rising out-of-pocket costs for employees, and an urgent need for a smarter approach to pharmacy benefits.
This article isn’t about assigning blame. It’s about giving brokers a practical guide to diagnosing why pharmacy costs are spiking after January 1 and what proactive steps you can take to help your clients regain control.
Why pharmacy costs spike after 1/1
(What carriers and traditional PBMs don’t proactively explain)
For most employers, the pharmacy cost spike after January 1 feels sudden. But in reality, it’s usually the result of several behind-the-scenes changes that all hit at once. The problem is that employees, and often employers, are rarely warned about how disruptive these changes can be.
Here’s what’s really happening.
-
Formulary changes catch employees off guard
One of the most common drivers of post-renewal frustration is a formulary change that no one fully anticipated.
At the start of a new plan year, medications are often:
- Moved to higher tiers
- Removed from the formulary altogether
- Reclassified in ways that increase cost sharing
In many cases, brand-name drugs replace lower-cost generics, not because they’re more effective, but because they generate higher rebates for traditional PBMs. While those rebates may look attractive on paper, they often lead to higher out-of-pocket costs for employees at the pharmacy counter.
On top of that, prior authorizations frequently reset on January 1. Employees who were stable on a medication in December suddenly face delays, denials, or new approval requirements in January. From their perspective, it feels like coverage was taken away overnight.
-
Copay accumulators and deductible resets
January is also when the financial reality of the plan year becomes very real.
As deductibles reset:
- Employees move from predictable copays to full deductible pricing
- Out-of-pocket costs jump immediately, often with the first refill
- Manufacturer copay assistance may no longer count toward the deductible due to copay accumulator programs
For employees, this is confusing and frustrating. They believe they’re “using their copay card,” but the deductible doesn’t move. For employers and brokers, it results in angry phone calls and confusion that’s difficult to unwind after the fact.
This is often the moment when pharmacy benefits become the number one complaint to HR early in the year.
Specialty and GLP-1 drug cost shock
Specialty medications are another major contributor to January cost spikes even though they’re used by a relatively small number of members.
Today, specialty drugs account for more than half of total pharmacy spend, despite serving only a fraction of the covered population. When deductibles reset and benefit structures change, the financial impact of these drugs becomes immediately visible.
GLP-1 medications used for diabetes and weight management add another layer of unpredictability. These drugs are high-cost, highly utilized, and often subject to changing coverage rules. A small shift in access or cost sharing can dramatically affect both employer spend and employee out-of-pocket costs.
For brokers, this combination (formulary changes, accumulator programs, deductible resets, and specialty drug pricing) explains why pharmacy benefits feel so unstable right after January 1.
And it sets the stage for a much bigger conversation about whether the traditional PBM model is actually aligned with employer and employee interests which is exactly where the discussion needs to go next.
The real issue: PBM misalignment and lack of transparency
By the time pharmacy costs spike after January 1, most brokers and employers are already deep into damage control. Employees are upset, HR is overwhelmed, and carriers and PBMs are offering explanations that rarely lead to real solutions.
That’s because the issue isn’t a single formulary change or deductible reset. The real problem is misalignment in the traditional PBM model.
Traditional Pharmacy Benefit Managers are often structured to prioritize:
- Rebate volume over lowest net cost
- Complex pricing structures over clarity
- Manufacturer incentives over employer outcomes
As a result, brokers and employers are frequently left without clear answers to basic questions, such as:
- What is the true cost of a medication?
- Where is pricing being marked up through spread pricing?
- How much of the rebate value is actually being passed back to the plan?
Without that visibility, pharmacy benefits become the most unpredictable and volatile part of the health plan especially after renewal.
Many employers assume pharmacy benefits are “set” once the plan year begins. In reality, PBM contracts often allow ongoing formulary shifts, pricing changes, and utilization management rules that directly affect both spend and employee experience. When those changes happen without transparency, confusion and frustration are almost inevitable.
This is why more brokers are starting to rethink the traditional PBM² approach altogether.
Instead of viewing pharmacy benefits as a black box managed by a carrier-aligned PBM, brokers are beginning to explore Pharmacy Benefit Solutions³ models designed to align pricing, transparency, and member experience with employer goals.
For brokers, this is a critical inflection point. Pharmacy benefits are no longer just an administrative component of the plan. They are a strategic lever that can either undermine client relationships or strengthen them depending on how they’re managed.
The broker’s role after January 1: From firefighting to strategy
For many brokers, the weeks following January 1 feel less like a fresh start and more like a scramble. Instead of focusing on growth or planning, time is spent responding to complaints, explaining unexpected costs, and trying to untangle pharmacy issues that no one flagged in advance.
But the role of the broker is changing.
Brokers are no longer just renewing plans and moving on to the next account. Clients now expect proactive guidance, clear explanations, and real strategies to control costs especially when pharmacy benefits become the most visible pain point early in the year.
This shift presents an opportunity.
Pharmacy benefits are no longer just an administrative line item buried in a larger health plan. They are one of the few areas where brokers can differentiate themselves by bringing insight, transparency, and solutions that directly improve the employee experience.
Unfortunately, the post-renewal environment often puts brokers in an unfair position.
When pharmacy costs spike:
- Carriers point fingers at PBMs, citing formulary rules or manufacturer pricing
- PBMs blame drug manufacturers, emphasizing market forces beyond their control
- Employers turn to brokers, looking for answers and accountability
Caught in the middle, brokers are expected to explain decisions they didn’t make and manage frustrations they didn’t cause. Without visibility into how pharmacy benefits are priced and managed, it becomes nearly impossible to move conversations forward.
This is where brokers can shift the narrative.
Instead of reacting to problems after they occur, brokers who take a more strategic approach to pharmacy benefits can:
- Anticipate post-renewal disruptions
- Set realistic expectations with clients before January 1
- Introduce solutions that stabilize costs throughout the year
Moving from firefighting to strategy doesn’t mean overhauling everything at once. It starts with recognizing that pharmacy benefits deserve the same level of attention and planning as medical coverage and that doing so strengthens the broker-client relationship long after renewal season ends.
What brokers can do right now to regain control
When pharmacy costs spike after January 1, it’s easy for conversations to become reactive. But brokers who step in with a clear plan can quickly shift the tone from frustration to confidence. Regaining control starts with focused, intentional action right now.
Here’s where brokers can make the biggest impact.
-
Conduct a post-renewal pharmacy review
The first step is understanding what’s actually driving the increase in pharmacy costs.
A post-renewal pharmacy review helps brokers:
- Identify high-cost claims that are disproportionately impacting spend
- Spot formulary disruptions that caught employees off guard
- Understand recurring employee complaints coming through HR
This review doesn’t need to be overly complex. Even a high-level analysis can uncover patterns that explain why costs jumped in January and where intervention can make a meaningful difference.
For brokers, this step alone often changes the conversation. Instead of guessing, you’re leading with insight.
-
Implement an Rx Optimization Program
Once cost drivers are identified, optimization becomes the next lever.
An effective Rx Optimization Program focuses on how and where medications are filled, not just whether they’re covered. This may include:
- Steering members toward lower-cost therapeutic alternatives
- Optimizing pharmacy channels, such as home delivery or preferred pharmacies
- Reducing unnecessary spend while maintaining access and continuity of care
The goal is alignment. When prescriptions are optimized correctly, employees see lower out-of-pocket costs, and employers gain better control over pharmacy spend without sacrificing outcomes.
-
Partner with a Pharmacy Benefit Solutions provider
Traditional PBM arrangements often limit how much influence brokers and employers have after the plan year begins. Partnering with a Pharmacy Benefit Solutions provider changes that dynamic.
These models emphasize:
- Transparent PBM pricing, so costs are clearly understood
- No spread pricing, eliminating hidden markups
- Member advocacy support, helping employees navigate pharmacy issues without overwhelming HR
Industry data shows that companies that switch to transparent PBMs or Pharmacy Benefit Solutions providers typically see 15 to 25 percent savings on pharmacy costs in the first year, reinforcing that meaningful improvement is possible even mid-year.⁴
For brokers, this approach restores leverage. Instead of reacting to problems created elsewhere, you’re offering clients a clear path forward, one that addresses both cost and experience.
How Intercept Rx supports brokers post-1/1
After January 1, brokers don’t need more explanations from carriers or more complexity from traditional PBMs. What they need is a partner that helps them stabilize pharmacy benefits, support employers, and reduce employee disruption throughout the year.
This is where Intercept Rx fits in.
Intercept Rx operates as a Pharmacy Benefit Solutions provider, combining the core functions of a PBM with a more transparent, proactive approach to pharmacy management. The model is intentionally designed for self-funded and level-funded plans, where visibility, flexibility, and control matter most.
Rather than treating pharmacy benefits as a fixed component of the plan, Intercept Rx focuses on ongoing optimization. The Rx Optimization Program is built to address the exact challenges brokers see after January 1, including rising costs, formulary disruptions, and employee confusion at the pharmacy counter.
Through optimization, Intercept Rx helps:
- Reduce out-of-pocket costs for employees by identifying lower-cost options and better fulfillment strategies
- Stabilize pharmacy spend throughout the year, not just at renewal
- Improve the member experience with advocacy support that helps employees navigate coverage questions, access issues, and cost concerns
For brokers, this approach changes the post-renewal conversation. Instead of reacting to problems after they surface, you’re equipped with a solution that brings clarity, transparency, and measurable improvement without waiting for the next plan year.
Most importantly, Intercept Rx’s model aligns pharmacy strategy with the broker’s role as a trusted advisor. The focus isn’t just on managing prescriptions, but on helping employers feel confident in their pharmacy benefits long after January 1 has passed.
Key Takeaway for Brokers
- Pharmacy cost spikes after January 1 are predictable, not random
- Post-renewal issues often stem from formulary changes, deductible resets, and opaque PBM structures
- Traditional PBM models create confusion, misalignment, and volatility for employers and employees
- Brokers who address pharmacy benefits early can reduce client frustration and churn
- A proactive pharmacy strategy positions brokers as trusted advisors, not problem solvers of last resort
